Veracyte Inc (VCYT) Unusual Options Activity Today

Checking VCYT unusual options activity helps you spot when traders are making outsized bets on Veracyte Inc before the broader market catches on. Veracyte Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor VCYT unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching VCYT unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking VCYT unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and VCYT unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; Percepta Genomic Sequencing Classifier and Percepta Nasal Swab Test for lung cancer diagnosis; Envisia Genomic Classifier for diagnosing interstitial lung disease, including idiopathic pulmonary fibrosis; and Immunoscore Colon Cancer test for colon cancer diagnosis.

It is also developing Percepta Genomic Atlas to help inform lung cancer treatment decisions; Envisia Classifier, the nCounter analysis system; and LymphMark for lymphoma subtyping test. Veracyte, Inc. has technology licensing and collaboration arrangements with Johnson & Johnson; Acerta Pharma; and CareDx. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.

Catalysts rarely arrive without a footprint, and VCYT unusual options activity is often where that footprint shows up first. Our scanner tracks Veracyte Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at VCYT unusual options volume on the call side or chasing put sweeps, Veracyte Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.